Smartphone AI test for cervical cancer screening
Part of Cancer, Women’s health & pregnancy clinical trials.
This study checks whether a smartphone-based AI tool can help screen for cervical cancer. You may be offered the AI-assisted screening during a clinic visit to see if it works well when visualizing the cervix.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to give free, informed consent and join voluntarily
- Have started sexual intercourse (the study excludes those who have never had sex)
- Not be pregnant at the screening visit
- Have a cervix that can be clearly seen during the screening (for example, heavy bleeding may prevent this)
- Do not have a past history of anogenital cancer, and none known at screening
- Have not had a hysterectomy (uterus removed) and be well enough for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two cervical screening approaches to find early signs of HPV-related changes. It may help by improving how results are sorted into “needs follow-up” versus “routine care,” especially for women with different HPV patterns.
This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.
This trial tests whether an AI chatbot can encourage women to take part in cervical cancer screening. It targets women who have not had a recent Pap test and who did not respond to an invitation letter, aiming to improve participation.
This trial tests whether giving women a self-collection kit to test for HPV at home can help catch cervical cancer early. It is for people who are overdue for screening and have access to a smartphone and the internet.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
This trial is testing a new screening tool (ELEVATE) to see how well it works in detecting cervical precancer. If you have an abnormal pap smear or a positive HPV test and are scheduled for a colposcopy, you may be able to help validate this tool.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.